SCNI (Scinai Immunotherapeutics Ltd) Sof foyda

SCNI (Scinai Immunotherapeutics Ltd.) - kompaniyaning tovar belgisi

Scinai Immunotherapeutics (SCNI) o'zining tadqiqot va ishlanmalar (R&D) strategiyasini dermatologiya uchun nanotantiqlarga yo'naltirayotgani sababli o'sishga tayyor bo'lib, ushbu tendentsiya kompaniyaning yillik moliyaviy natijalari bilan tasdiqlangan. -0.00 darajasi ushbu ko'rsatkichning joriy miqdorini aks ettiradi. Psoriazni davolashdagi progress va patent himoyasi asosiy drayverlar bo'lib xizmat qilmoqda. Dori vositalarini tashish paytida sovuq zanjirning qat'iy nazorati barqaror sifatni ta'minlaydi. Grafikdagi narx harakati keskin impulsiv harakatlar paytida haddan tashqari ko'p to'lov qilish xavflari haqida ogohlantirmoqda.

SCNI (Scinai Immunotherapeutics) Sof foyda tarixi 21.02.2024dan 01.11.2026gacha

Scinai Immunotherapeutics Ltd. (SCNI) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari BiondVax Pharmaceuticals|SCNI - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi BiondVax Pharmaceuticals|SCNI - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Scinai Immunotherapeutics|SCNI - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi scinai.com|SCNI - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Scinai Immunotherapeutics|SCNI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Scinai Immunotherapeutics Ltd|SCNI - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar BiondVax Pharmaceuticals|SCNI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Scinai Immunotherapeutics|Shoshilinch likvidlik scinai.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
SCNI - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Scinai Immunotherapeutics
Scinai asosiy tovari

Scinai Immunotherapeutics (SCNI) kompaniyasining fundamental barqarorligini baholash uchun investorlar kunlik intervaldagi prognoz qilingan sof foyda orqali operatsion samaradorlik tendentsiyalarini tahlil qilishlari kerak. Tashkilotning sof moliyaviy natijasini tahlil qilish orqali ortiqcha to'lov riski va o'sish potentsiali o'rtasidagi muvozanatni aniqlash mumkin, bu esa gripp va COVID-19 pandemiyalariga qarshi innovatsion himoyani yaratuvchi noyob nanotana platformasiga ega bo'lgan biotexnologiya firmasi uchun juda muhimdir.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Sof moliyaviy natija Pharming Corp PHAR|NKTR: Sof foyda|Sof daromad upstreambio.com|ZBIO (Zenas Biopharma) - Sof foyda|Immunome Inc (IMNM) - Sof moliyaviy natija|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KalVista Corp - Kompaniya foydasi|Sof foyda SEPN (Septerna Inc)|Sof foyda pieris.com PVLA|Savara - Sof foyda|Sof moliyaviy natija Rigel Pharma RIGL|ANAB (AnaptysBio Corp) - Sof daromad|Astria Corp - Yakuniy foyda|ENGN (enGene Holdings Inc.) - Sof foyda|rapt.com (RAPT) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|Sof daromad Aclaris Therapeutics Inc. ACRS|Kompaniyaning sof foydasi Kyverna KYTX|TLSA - Sof daromad|CABA: Sof daromad|VTYX - Sof foyda|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Kompaniya foydasi AVTX|Kompaniyaning sof foydasi Eledon|Kompaniyaning sof daromadi Agenus, Inc AGEN|Sof daromad CLYM (Climb Bio Inc)|Soliqlar to‘langandan keyingi foyda ZURA|Sof foyda ATYR (aTyr Pharma)|Yakuniy foyda ADAG|Ikena Oncology, Inc. - Sof foyda|Kompaniyaning sof daromadi Shattuck Labs, Inc.|equilliumbio.com (EQ) - Kompaniyaning sof foydasi|Connect Biopharma Holdings Limited - Yakuniy foyda|IMUX (Immunic Therapeutics) - Sof foyda|Sof foyda Atara Biotherapeutics Inc|Kompaniyaning sof foydasi InflaRx N.V. (IFRX)|XFOR: Soliqdan keyingi foyda|Sof foyda ACET (Adicet Bio, Inc.)|Celularity Inc (CELU) - Kompaniyaning sof daromadi|INMB: Sof daromad|BRNS - Sof foyda|KZR (Kezar Life Sciences, Inc) - Sof daromad|SABS: Soliqlar to‘langandan keyingi foyda|AKTX (Akari Therapeutics) - Sof foyda|Enlivex Therapeutics, Ltd. (ENLV) - Sof moliyaviy natija|Sof foyda QTTB|Sof daromad GeoVax Labs GOVX|Kompaniyaning sof foydasi Edesa EDSA|Sof moliyaviy natija iBio Corporation (IBIO)|CARM - Kompaniyaning sof foydasi|Sof moliyaviy natija xtlbio.com XTLB|BOLT: Sof foyda|Sof daromad HCW Biologics|Kompaniyaning sof foydasi Aptevo Therapeutics, Inc.|Kompaniya foydasi AIM (aimimmuno.com)|Sof foyda ADTX|Sof moliyaviy natija gribio.com|Kompaniyaning sof foydasi XORTX Therapeutics XRTX|HIND (Vyome Holdings Inc.) - Soliqdan keyingi foyda|Revelation Bio - Sof foyda|Yakuniy foyda INDP (Indaptus Corp)|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Kompaniyaning sof foydasi Allakos Inc|HOOK: Yakuniy foyda|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Sof foyda OCEA (Ocean Biomedical, Inc.)|Sof foyda tcbiopharm.com TCBP|THRD: Sof daromad